Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mannitol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 131 for your search:
Start Over
Phase II/III Combination Chemotherapy with FAME (5-FU/ADR/MeCCNU) vs FAP (5-FU/ADR/CACP) vs FAME Alternating with TZT vs 5-FU Alone for Advanced Gastric Carcinoma (Summary Last Modified 07/90)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-834151, MAYO-834151, NCCTG-83-41-51
Phase II/III Chemotherapy with Intraperitoneal CDDP in Patients with Ovarian Carcinoma Limited to the Peritoneal Cavity
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCLA-81021523, NCI-V83-0303
Phase II/III Randomized Comparison of PF (CACP/5-FU) vs MVPF (MITO/VCR/CACP/5-FU) in Advanced Large Bowel Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1285
Phase III Randomized Comparison of Combination Chemotherapy with CBDCA/CTX vs CACP/CTX in Patients with Stage III/IV Ovarian Carcinoma
Phase: Phase III, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8412
Phase III Preoperative Radiotherapy plus MTX/BLEO/CACP vs Conventional Therapy for Stage III-IV and Recurrent Intraoral Squamous Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 85 and under
Sponsor:
Protocol IDs: NCI-D78-005-053, CCOG-784
Phase III Preoperative Chemotherapy with CACP/MTX/BLEO/VCR plus Postoperative Radiotherapy for Untreated Stage III-IV Head & Neck Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-035-102
Phase III Combination Chemotherapy with VBL/BLEO and Sequential Chemotherapy with CACP for Advanced Testicular and Extragonadal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDAR-175
Phase III VAM (VCR/ADR/MTX) vs ADR for Thyroid Carcinoma Not Amenable to Other Therapy Modalities
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D79-026-161, RPMI-997906
Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: NCI-78-C-56, NCI-NMOB-814
Phase III Randomized Evaluation of Surgery plus Pre- and Postoperative Adjuvant Chemotherapy with DVB (CACP/BLEO/DAVA) vs Surgery Alone for Esophageal Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-81-C-118, NCI-T83-0978N, T83-0978
Phase III Randomized Chemotherapy with CP (CTX/CACP) vs CAP (CTX/ADR/CACP) in Optimal Stage III Ovarian Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-52
Phase III Chemotherapy with DAVA/CACP vs CAP (CTX/ADR/CACP) vs Supportive Care Only in the Management of Extensive non-Small Cell Carcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: CAN-NCIC-BR5, NCI-V83-0066, BR5
Phase III Chemotherapy with ADR plus CACP for Genitourinary Carcinoma and Cancer of the Cervix and Ovary
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7606
Phase III Randomized Trial of Adjuvant Chemotherapy with CACP/5-FU Prior to Preoperative or Primary Radiotherapy in High-Risk Patients with Head and Neck Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MCW-HRRC-4479, NCI-V83-0194
Phase III Chemotherapy with Continuous Infusion ADR in Conjunction with Other Drugs in the Treatment of Stage III Metastatic Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UCCRC-3717A, NCI-V83-0120
Phase III Chemotherapy with HCAP (CTX/ADR/CACP/HMM) vs CP (CTX/CACP) for Stage III/IV Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-806151
Phase III Randomized Comparison of 5-FU vs Mallinson Regimen vs FAP (5-FU/ADR/CACP) in Patients with Advanced Adenocarcinoma of the Pancreas
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-834351, MAYO-834351, NCCTG-83-43-51
Phase III Surgery and Radiotherapy with and without CACP/5-FU for Stage III Head and Neck Squamous Cell Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: RTOG-8322, EST-8322
Phase III Comparison of DAVA vs DAVA/MITO vs DAVA/CACP in Patients with Advanced non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-LUN-301
Phase III Combination Chemotherapy with CECA (CACP/VM-26/CTX/ADR) in Children Aged 1 Year and Older with Stage D Neuroblastoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8441
Phase III Randomized Comparison of CTX/CACP vs CTX/CBDCA in Patients with Stage III/IV Ovarian Carcinoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-846151, MAYO-846151, NCCTG-84-61-51
Phase III Comparison of MITO vs MVP (MITO/VBL/CDDP) in the Treatment of Advanced Squamous Cell Carcinoma of the Lung (Summary Last Modified 02/89)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-852251, NCCTG-85-22-51
Start Over